A phase II trial of concurrent chemoradiaiton with paclitaxel/carboplatin in high-risk cervical cancer patients after radical hysterectomy: A multicenter prospective Korean study

被引：0
|
作者：
Lee, T.
Kang, S.
Kim, Y.
Park, B.
Kim, Y.
Lee, J.
Kim, S.
Kim, Y.
Kim, J.
Kim, K.
机构：
[1] Seoul Boramae Metropolitan Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
[3] Asan Med Ctr, Seoul, South Korea
[4] East West Neo Med Ctr, Seoul, South Korea
[5] Chonnam Natl Univ, Coll Med, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Seoul, South Korea
[7] Hanyang Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5598
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemoradiation With Paclitaxel and Carboplatin in High-Risk Cervical Cancer Patients After Radical Hysterectomy: A Korean Gynecologic Oncology Group Study
    Lee, Taek Sang
    Kang, Soon Beom
    Kim, Young Tak
    Park, Byung Joo
    Kim, Yong Man
    Lee, Jong Min
    Kim, Seok Mo
    Kim, Young Tae
    Kim, Jae Hoon
    Kim, Kyung Tai
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 304 - 310
  • [2] Is concurrent chemoradiation a choice for high-risk cervical cancer patients after radical hysterectomy?
    Wang, Peng-Hui
    Cheng, Ming-Huei
    Yuan, Chiou-Chung
    Yen, Ming-Shyen
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (01) : 102 - 103
  • [3] Prospective phase I/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy
    Grigsby, PW
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 860 - 864
  • [4] Risk factors of recurrence after adjuvant concurrent chemoradiotherapy following radical hysterectomy in high-risk patients with cervical cancer
    Chung, H.
    Kim, J.
    Park, N.
    Song, Y.
    Kang, S.
    Lee, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study
    Tanioka, Maki
    Yamaguchi, Satoshi
    Shimada, Muneaki
    Nagao, Shoji
    Takehara, Kazuhiro
    Nishimura, Masato
    Morita, Satoshi
    Negoro, Shunichi
    Fujiwara, Kiyoshi
    Kigawa, Junzo
    [J]. MEDICAL ONCOLOGY, 2017, 34 (08)
  • [6] Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study
    Maki Tanioka
    Satoshi Yamaguchi
    Muneaki Shimada
    Shoji Nagao
    Kazuhiro Takehara
    Masato Nishimura
    Satoshi Morita
    Shunichi Negoro
    Kiyoshi Fujiwara
    Junzo Kigawa
    [J]. Medical Oncology, 2017, 34
  • [7] A phase II trial of radiation therapy with concurrent paclitaxel chemotherapy in high-risk endometrial cancer patients after staging operation: An interim analysis of a prospective multicenter trial (KGOG2001)
    Kim, J.
    Jeong, J.
    Nam, B.
    Kim, S.
    Cho, C.
    Kim, B.
    Lee, J.
    Kim, Y.
    Bae, D.
    Kang, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial
    Lahousen, M
    Haas, J
    Pickel, H
    Hackl, A
    Kurz, C
    Ogris, H
    Stummvoll, W
    Winter, R
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (02) : 196 - 201
  • [9] Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy
    Kim, Hakyoung
    Cho, Won Kyung
    Kim, Yeon Joo
    Kim, Young Seok
    Park, Won
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 423 - 428
  • [10] PHASE II STUDY OF TRIWEEKLY CARBOPLATIN PLUS DOSE DENSE PACLITAXEL BEFORE AND AFTER RADICAL HYSTERECTOMY FOR LOCALLY ADVANCED CERVICAL CANCER.
    Nagao, S.
    Yamamoto, K.
    Nonaka, M.
    Shiroyama, Y.
    Oishi, T.
    Yamaguchi, S.
    Takehara, K.
    Shimada, M.
    Kigawa, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 347 - 347
12345